QuickStrip

QuickStrip

Share

QuickStrip™ is Rapid Dose Therapeutics’ (RDT) game-changing, proprietary drug delivery system. QuickStrip is an oral, thin, dissolving strip that’s placed on or under your tongue — and can deliver the active ingredient quickly into the bloodstream for rapid results. RDT is a Canadian publicly traded Canadian life-sciences company that provides innovation, proprietary drug delivery technologies des

Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Secures Patent for QuickStrip™ Ni****ne Oral Film Targeting $38B Smoke-Free Ni****ne Market - Rapid Dose Therapeutics 03/05/2026

Major Patent Milestone!

Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Secures Patent for QuickStrip™ Ni****ne Oral Film Targeting $38B Smoke-Free Ni****ne Market

Key Highlights for Investors:

• Massive Addressable Market: The global modern oral ni****ne market is projected to reach $38.89 Billion by 2033, growing at a 19% CAGR.

• Global IP Footprint: This grant follows our 2025 WIPO PCT filing, extending potential protection to up to 158 jurisdictions worldwide.

• Strategic Advantage: Partnered with Aavishkar Oral Strips, we are positioned to disrupt traditional ni****ne delivery with a discreet, smoke-free alternative.

• Ongoing Discussions: RDT remains engaged in commercial discussions with a major global ni****ne company, a relationship now backed by stronger IP.

Read the full press release here:
https://rapid-dose.com/rapid-dose-therapeutics-cse-dose-otcqb-rdtcf-secures-patent-for-quickstrip-ni****ne-oral-film-targeting-38b-smoke-free-ni****ne-market/

****neReplacement $DOSE $RDTCF

Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Secures Patent for QuickStrip™ Ni****ne Oral Film Targeting $38B Smoke-Free Ni****ne Market - Rapid Dose Therapeutics BURLINGTON, Ontario — March 5, 2026 — Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company specializing in oral thin film drug delivery technology, today announced the grant of a key patent for its QuickStrip™ Ni****ne Bilayer Oral Film in partnership with...

Rapid Dose Therapeutics Releases Ni****ne Business Update and Extends Collaboration with International Ni****ne Partner 10/20/2025

RDT advances NicStrip(TM) commercialization with $1.8 million CAD extension

https://www.newsfilecorp.com/release/271072

****neAlternatives ****neMarket $DOSE

Rapid Dose Therapeutics Releases Ni****ne Business Update and Extends Collaboration with International Ni****ne Partner Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian...

Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip™ to Combat Op**te Addiction Crisis - Rapid Dose Therapeutics 07/31/2025

Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip™ to Combat **te Crisis

https://shorturl.at/O4JX6

Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip™ to Combat Op**te Addiction Crisis - Rapid Dose Therapeutics Burlington, Ontario – July 29, 2025– Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company, is proud to announce the launch of a new significant harm reduction initiative aimed at addressing the devastating opioid crisis gripping Canada’s ...

Want your practice to be the top-listed Clinic in Burlington?
Click here to claim your Sponsored Listing.

Telephone

Address


1121 Walker's Line, Unit 3A
Burlington, ON
L7N2G4

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm